Bipartisan Michigan lawmakers unveil a bill subjecting US-China biotech deals to outbound investment screening, citing national security risks.
Rep. John Moolenaar (R-MI) (Lenin Nolly/Sipa USA/Sipa via AP Images)
June 2, 2026 08:00 AM EDT
DealsChinaPharmaFDA+
Exclusive: Bipartisan group of lawmakers unveil new bill to restrict China biotech
Max Bayer
美国国会两党议员星期二(6月2日)联合提出一项立法，旨在防止美国制药和生物技术领域的投资流向中国企业。提出该项立法的国会议员表示，此举对于保护美国的药品供应链和研发基础、防范外国对手渗透至关重要。
A key US House Republican urges Treasury to restrict US investment in China biotech, spotlighting Bristol Myers Squibb's Hengrui…
Michigan lawmakers introduced a bipartisan bill to ban Chinese-connected vehicles and technology from the U.S. market over…
Critics say bill would weaken U.S. science by cutting flows of ideas and talent
As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to block…
China's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?
The next tech war? Why biotech may become a new US-China battleground
